JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Cysteine‑ and glycine‑rich protein 2: A vital regulator that inhibits necroptosis glioma cell by activating the JAK‑STAT1 pathways

  • 0Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China.
Oncology Reports +

|

February 7, 2025

|

February 7, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Cysteine- and glycine-rich protein 2 (CSRP2) promotes glioma invasion and metastasis by inhibiting necroptosis. Silencing CSRP2 activates necroptosis via the JAK-STAT1 pathway, offering a potential therapeutic target for glioma.

Area Of Science

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background

  • Cysteine- and glycine-rich protein 2 (CSRP2) is linked to tumor invasion and metastasis.
  • CSRP2 is upregulated in glioma and correlates with tumor stage.
  • CSRP2 overexpression enhances glioma cell proliferation and metastasis, while knockdown inhibits these functions.

Purpose Of The Study

  • To investigate the role of CSRP2 in glioma progression.
  • To elucidate the molecular mechanisms underlying CSRP2's function in glioma, focusing on cell death pathways.
  • To explore the relationship between CSRP2, the JAK-STAT1 pathway, and necroptosis in glioma.

Main Methods

  • Transcriptome sequencing of CSRP2-knockdown U251M cells.
  • Flow cytometry, Hoechst 33342/PI dual staining, and transmission electron microscopy to assess necroptosis.
  • Western blotting to analyze JAK-STAT1 pathway activation and necroptosis-related protein phosphorylation.
  • Inhibition of the JAK-STAT1 pathway using ruxolitinib.

Main Results

  • CSRP2 knockdown inhibited the JAK-STAT1 signaling pathway and enriched genes involved in necroptosis.
  • CSRP2 overexpression suppressed necroptosis in glioma cells.
  • CSRP2 overexpression activated the JAK-STAT1 signaling pathway.
  • JAK-STAT1 inhibition promoted phosphorylation of necroptosis proteins (RIPK1, RIPK3, MLKL).

Conclusions

  • CSRP2 plays a crucial role in promoting glioma invasion and metastasis.
  • CSRP2 inhibits necroptosis in glioma cells, potentially by maintaining JAK-STAT1 pathway activation.
  • CSRP2 may inhibit necroptosis by suppressing the protein inhibitor of activated STAT1, thereby sustaining JAK-STAT1 activation.
  • Targeting CSRP2 or the JAK-STAT1 pathway could be a therapeutic strategy for glioma.

Keywords:

Related Concept Videos

The JAK-STAT Signaling Pathway 01:20

8.6K

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...

The Intrinsic Apoptotic Pathway 01:31

6.1K

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

Necrosis 01:16

4.1K

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

Caspases 01:24

12.0K

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...

Amplifying Signals via Enzymatic Cascade 01:22

8.2K

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...

The Extrinsic Apoptotic Pathway 01:17

6.0K

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...